Thrombosis Voices in Partnership Programme (ViPs)
AntiCoagulation Europe (ACE) are working in partnership with LEO Pharma and their research partners to find people who have cancer and have experienced a blood clot, either whilst being treated for their cancer or shortly afterwards. This would have been called a deep vein thrombosis (DVT) and or a pulmonary embolism (PE). We would like you to join the ViP programme.
The ViP programme is designed to bring patients with similar experiences together, so that they can share their stories and help to build activities and ideas which will improve the patient experience for many others.
Participants can choose how much or how little they would like to be involved as the programme evolves, but a key first date is Wednesday May 4th when ACE and LEO Pharma will be inviting patients to a day at the Leo offices in Hurley, Berkshire. As well as travel expenses, you would be paid a fee for your participation.
Even if you cannot make the first meeting on the 4th of May, if you are interested, please do still contact us.
Patients who have already been involved in similar programmes have found that they have benefited hugely by being able to share their stories with others who may have been through similar experiences, and by being part of such a programme are able to make a real difference to help improve those living with specific conditions.
Please email us if you wish to find out more.
admin@anticoagulationeurope.org
New to Apixaban, changing from Warfarin.
Do you need to be weaned off Rivaroxaban?
Corona Virus/ Xarelto and immunity 
DVT recovery 6 months in
Hrt and Warfarin
